2022-05-26 | NDAQ:OCX | Press Release | ONCOCYTE CORPORATION
(2022-05-26 | NDAQ:OCX) Oncocyte Presents DetermaIO(TM) Data at ASCO 2022 Supporting the Test's Potential to Expand the Clinical Use of Immunotherapy
Source: stockhouse.com
📰 Rob Seitz News
Rob Seitz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rob Seitz. Real-time updates on events, politics, business and more.
Oncocyte Publishes Study Demonstrating Predictive Potential
Data show that DetermaIO demonstrates superior accuracy compared to standard of care PD-L1 IHC for predicting a patient’s response to immunotherapy...
Oncocyte Determa Neoadjuvant Immunochemotherapy Rob Seitz Bob Yedid Megan Kernan Exchange Commission
Source: globenewswire.com